10-Q/AThe Record
Spyre Therapeutics, Inc. files 10-Q/A
Filed Nov 18, 2024 · 1y ago · Accession 0001636282-24-000113
Plain English
Quarterly report — three-month financials and management discussion.
Read the source below for the full document.
Filing details
- Company
- Spyre Therapeutics, Inc.
- Ticker
- SYRE
- CIK
- 1636282
- Form type
- 10-Q/A
- Filing date
- Nov 18, 2024
- Report date
- Sep 30, 2024
- Document
- syre-20240930.htm
- Size
- 7.9 MB